Umary for pain: FDA found three undeclared drugs

Umary is promoted for pain, but FDA testing found that some additional versions contained medicines missing from the label. In its April 7, 2026 update, FDA said tested versions sold on ibeautistore.com contained diclofenac, dexamethasone and omeprazole. FDA advises consumers not to buy or use Umary products. [1]

What the latest FDA update says

The three substances were not listed on the product label. FDA's page also records earlier findings in other Umary versions: additional versions tested in February 2026 contained diclofenac, while versions described in 2024 contained diclofenac and omeprazole. These are product-specific test reports; they do not identify the contents of every bottle or establish one formula shared by all sellers. [1]

Why the hidden ingredients matter

Diclofenac is an anti-inflammatory pain medicine; its prescribing information warns of serious cardiovascular events and stomach or intestinal bleeding, ulceration and perforation. Dexamethasone is a corticosteroid: FDA warns it can raise blood sugar, weaken infection defenses and, with prolonged or high-dose use, suppress the adrenal gland. Stopping suddenly can cause withdrawal, as the drug label also explains. Omeprazole is an acid-reducing medicine with known adverse reactions and interactions. With undeclared ingredients, users cannot make an informed decision about dose or combinations. [1][3][4][5]

If you are taking Umary now

Do not try to manage this alone or abruptly stop a long-running product. FDA says current users should promptly consult a healthcare professional about how to discontinue safely and assess possible steroid-related withdrawal or adrenal effects. Bring the bottle or clear photos of the label and tell the clinician how long and how often you used it. Seek urgent care for severe or rapidly worsening symptoms. FDA accepts suspected adverse-event reports through MedWatch. [1]

A separate Canadian warning

Health Canada issued a separate advisory in 2024 after finding diclofenac and omeprazole in an unauthorized Canadian-market Umary product and later dexamethasone in another version. The agency said no Umary products were authorized for sale in Canada at that time. This is a dated Canadian notice about different versions; it does not establish today's Canadian authorization status or the formula of the U.S. samples tested in 2026. [2]

What is known—and what is not

FDA reports laboratory findings in additional versions associated with named online sources at particular dates. The agency does not publish the measured amount in each unit or establish that every Umary bottle is identical. The warning is not evidence against all hyaluronic-acid products or every pain treatment. It is a direct warning about this product name: avoid buying or using it, and get medical guidance if you already have. [1]

Which undeclared ingredients did FDA report in 2026?

The April 7 update names diclofenac, dexamethasone and omeprazole in tested additional versions sold on ibeautistore.com. A separate February 2026 update reported diclofenac in other versions. [1]

Should I stop Umary immediately?

Contact a healthcare professional promptly before changing use. FDA specifically says Umary should be discontinued safely because corticosteroid withdrawal and adrenal suppression need professional assessment. [1]

Our recommendation

We do not recommend Umary. FDA found undeclared prescription medicines in additional versions, including a corticosteroid that can make abrupt stopping unsafe. Current users should speak with a healthcare professional promptly. [1]